Germany-based company receives approval to grow MMJ in Zimbabwe

The Ministry of Health of Zimbabwe has approved Amatheon Agri’s license to produce cannabis for medical and scientific use.

The company now embarks on an assessment and planning phase for growing and producing an assortment of cannabidiol (CBD) products.

The global medical cannabis industry was estimated to be worth around US$21 billion in 2020, with very high estimated annual growth rates over the next five years as an increasing number of countries approve its use.

Amatheon Agri’s subsidiary in Zimbabwe was established in 2014 and seeks a first-mover advantage as the country reengages with the international community and promotes agricultural investment.


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber